Feb 13, 2020 / 01:30PM GMT
Operator
Good morning, and welcome to Evelo's conference call to discuss the fourth quarter and full year 2019 financial results and business highlights. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
At this time, I'd like to turn the call over to Jessica Cotrone of Evelo. Please proceed.
Jessica Cotrone - Evelo Biosciences, Inc. - VP & Head of Communications
Thank you, Sarah. This morning, we issued a press release that outlines the topics we plan to discuss today. This release is available at www.evelobio.com under the Investors tab.
Today on our call, Simba Gill, Chief Executive Officer; Duncan McHale, Chief Medical Officer; Mark Bodmer, President of R&D and Chief Scientific Officer; and Jonathan Poole, Chief Financial Officer, will review the fourth quarter and full year 2019 financial results and some recent business highlights.
Before we begin, I would like to remind everyone that statements made during this
Q4 2019 Evelo Biosciences Inc Earnings Call Transcript
Feb 13, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers